The UAE Ministry of Health and Prevention (MOHAP) and the Dubai Health Authority (DHA) regulate medicines in the Emirates. Medicines and medical products must be registered before they can be legally sold, prescribed, or possessed. The UAE’s drug laws are famously strict — the federal penal framework (Law No. 14 of 1995 on combating narcotics, as amended) sets severe penalties for unlicensed substances, and courts have historically applied them harshly to both residents and visitors.

GLP-1 receptor agonists (semaglutide/Ozempic, tirzepatide/Mounjaro) are registered prescription medicines in the UAE — legally available at licensed pharmacies with a doctor’s prescription, widely used for diabetes and weight management. Peptides like BPC-157, GHK-Cu, CJC-1295, TB-500, and research-only GLP-1s (retatrutide) are NOT registered for human use — possessing, selling, or importing them is unlawful, even for personal use.

Community reports and news coverage describe packages of unregistered medicines and peptide vials being intercepted at UAE customs, with consequences ranging from confiscation to legal proceedings. There is no grey-zone-friendly postal route that is “safe” — the Emirates’ enforcement posture on unregistered medicines is one of the strictest globally. Treat any international peptide order as a serious legal risk.

For Dubai expats: (1) registered GLP-1s via licensed clinics/pharmacies with a prescription are the only lawful route; (2) unregistered research peptides carry real criminal-law exposure — not just confiscation; (3) rules and registered-product lists change — check MOHAP/DHA current status before any decision; (4) this is NOT legal advice — for certainty, consult a UAE-qualified lawyer.